ABO식 혈액형 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "ABO식 혈액형" in Korean language version.

refsWebsite

Global rank Korean rank

25doi.org

2^nd place

3^rd place

24nih.gov

4^th place

12semanticscholar.org

11^th place

310^th place

9archive.org

6^th place

18^th place

8worldcat.org

5^th place

11^th place

5web.archive.org

1^st place

1isbtweb.org

low place

1arxiv.org

69^th place

54^th place

1harvard.edu

18^th place

27^th place

1kosis.kr

4,863^rd place

53^rd place

1metapress.com

8,671^st place

4,188^th place

1gifu-u.ac.jp

low place

1socalredcross.org

low place

1sciam.com

6,119^th place

2,741^st place

1dongascience.com

low place

301^st place

archive.org

Maton, Anthea; Jean Hopkins; Charles William McLaughlin; Susan Johnson; Maryanna Quon Warner; David LaHart; Jill D. Wright (1993). 《Human Biology and Health》. Englewood Cliffs, New Jersey, USA: Prentice Hall. ISBN 978-0-13-981176-0.
Ogasawara K; Bannai M; Saitou N; 외. (1996). “Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes”. 《Human Genetics》 97 (6): 777–83. doi:10.1007/BF02346189. PMID 8641696. S2CID 12076999.
Sarode, R; Goldstein J; Sussman II; Nagel RL; Tsai HM (June 2000). “Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor”. 《Br J Haematol》 109 (4): 857–64. doi:10.1046/j.1365-2141.2000.02113.x. PMID 10929042. S2CID 25343413.
O'Donnell, J; Boulton FE; Manning RA; Laffan MA (2002년 2월 1일). “Amount of H antigen expressed on circulating von Willebrand factor is modifiedby ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels”. 《Arterioscler Thromb Vasc Biol》 22 (2): 335–41. doi:10.1161/hq0202.103997. PMID 11834538. S2CID 325644.
Bowen, DJ; Collins PW; 외. (March 2005). “The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype”. 《Br J Haematol》 128 (6): 830–6. doi:10.1111/j.1365-2141.2005.05375.x. PMID 15755288. S2CID 45434815.
Bongers T; de Maat M; van Goor M; 외. (2006). “High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability”. 《Stroke》 37 (11): 2672–7. doi:10.1161/01.STR.0000244767.39962.f7. PMID 16990571.
von Dungern, Emil; Hirszfeld, Ludwik (1910). “Über Vererbung gruppenspezifischer Strukturen des Blutes”. 《Zeitschrift für Immunitätsforschung und Experimentelle Therapie》 (G. Fischer.): 284–292. Die Vererbung der durch Isoagglutinine nachweisbaren spezifischen Strukturen A und B der menschlichen Blutkfirper erfolgt nach der Mendelschen Regel, wobei die Eigenschaft der Struktur dominant ist, das Fehlen der Struktur rezessiv. Die Tatsache, dafi die nachweisbaren Bestandteile der Blutkorper niemals rezessiv sind und daher bei den Kindern nie erscheinen, wenn nicht einer der Eltern sie enthait, ist forensisch zu verwerten.
Doan, C.A. (1927). “The Transfusion problem”. 《Physiological Reviews》 7 (1): 1–84. doi:10.1152/physrev.1927.7.1.1. ISSN 0031-9333.
Garratty, G.; Dzik, W.; Issitt, P.D.; Lublin, D.M.; Reid, M.E.; Zelinski, T. (2000). “Terminology for blood group antigens and genes-historical origins and guidelines in the new millennium”. 《Transfusion》 40 (4): 477–489. doi:10.1046/j.1537-2995.2000.40040477.x. ISSN 0041-1132. PMID 10773062. S2CID 23291031.

arxiv.org

Segurel, L.; Thompson, E. E.; Flutre, T.; Lovstad, J.; Venkat, A.; Margulis, S. W.; Moyse, J.; Ross, S.; Gamble, K.; Sella, G.; Ober, C. (2012). “The ABO blood group is a trans-species polymorphism in primates”. 《Proceedings of the National Academy of Sciences》 (영어) 109 (45): 18493–18498. arXiv:1208.4613. Bibcode:2012PNAS..10918493S. doi:10.1073/pnas.1210603109. PMC 3494955. PMID 23091028.

doi.org

dx.doi.org

Storry, J. R.; Castilho, L.; Chen, Q.; Daniels, G.; Denomme, G.; Flegel, W. A.; Gassner, C.; de Haas, M.; 외. (2016). “International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings”. 《ISBT Science Series》 11 (2): 118–122. doi:10.1111/voxs.12280. ISSN 1751-2816. PMC 5662010. PMID 29093749.
Muramatsu M, Gonzalez HD, Cacciola R, Aikawa A, Yaqoob MM, Puliatti C (2014). “ABO incompatible renal transplants: Good or bad?”. 《World Journal of Transplantation》 4 (1): 18–29. doi:10.5500/wjt.v4.i1.18. ISSN 2220-3230. PMC 3964193. PMID 24669364.
Segurel, L.; Thompson, E. E.; Flutre, T.; Lovstad, J.; Venkat, A.; Margulis, S. W.; Moyse, J.; Ross, S.; Gamble, K.; Sella, G.; Ober, C. (2012). “The ABO blood group is a trans-species polymorphism in primates”. 《Proceedings of the National Academy of Sciences》 (영어) 109 (45): 18493–18498. arXiv:1208.4613. Bibcode:2012PNAS..10918493S. doi:10.1073/pnas.1210603109. PMC 3494955. PMID 23091028.
Seltsam A, Hallensleben M, Kollmann A, Blasczyk R (2003). “The nature of diversity and diversification at the ABO locus”. 《Blood》 102 (8): 3035–42. doi:10.1182/blood-2003-03-0955. PMID 12829588.
Ogasawara K; Bannai M; Saitou N; 외. (1996). “Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes”. 《Human Genetics》 97 (6): 777–83. doi:10.1007/BF02346189. PMID 8641696. S2CID 12076999.
Shastry, S; Bhat, S (October 2010). “Imbalance in A2 and A2B phenotype frequency of ABO group in South India”. 《Blood Transfusion》 8 (4): 267–270. doi:10.2450/2010.0147-09. PMC 2957492. PMID 20967168.
Cserti, CM; Dzik, WH (2007). “The ABO blood group system and Plasmodium falciparum malaria”. 《Blood》 110 (7): 2250–2258. doi:10.1182/blood-2007-03-077602. PMID 17502454.
Calafell, Francesc; 외. (September 2008). “Evolutionary dynamics of the human ABO gene”. 《Human Genetics》 124 (2): 123–135. doi:10.1007/s00439-008-0530-8. PMID 18629539. S2CID 12450238.
Jan Van Oss, Carel (2004). “Letter to the Editor: "Natural" Versus Regular Antibodies”. 《The Protein Journal》 23 (6): 357; author reply 359–60. doi:10.1023/B:JOPC.0000039625.56296.6e. PMID 15517982. S2CID 189929325. 2011년 7월 14일에 원본 문서에서 보존된 문서. 2009년 11월 28일에 확인함.
Seymour, R. M.; Allan, M. J.; Pomiankowski, A; Gustafsson, K (2004). “Evolution of the human ABO polymorphism by two complementary selective pressures”. 《Proceedings of the Royal Society B: Biological Sciences》 271 (1543): 1065–1072. doi:10.1098/rspb.2004.2674. PMC 1691687. PMID 15293861.
Reid, ME; Mohandas, N (2004). “Red blood cell blood group antigens: structure and function.”. 《Seminars in Hematology》 41 (2): 93–117. doi:10.1053/j.seminhematol.2004.01.001. PMID 15071789.
Mohandas, N; Narla, A (2005). “Blood group antigens in health and disease.”. 《Current Opinion in Hematology》 12 (2): 135–40. doi:10.1097/01.moh.0000153000.09585.79. PMID 15725904. S2CID 19866834.
Sarode, R; Goldstein J; Sussman II; Nagel RL; Tsai HM (June 2000). “Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor”. 《Br J Haematol》 109 (4): 857–64. doi:10.1046/j.1365-2141.2000.02113.x. PMID 10929042. S2CID 25343413.
O'Donnell, J; Laffan MA (August 2001). “The relationship between ABO histo-blood group, factor VIII and von Willebrand factor”. 《Transfus Med.》 11 (4): 343–51. doi:10.1046/j.1365-3148.2001.00315.x. PMID 11532189. S2CID 23603864.
O'Donnell, J; Boulton FE; Manning RA; Laffan MA (2002년 2월 1일). “Amount of H antigen expressed on circulating von Willebrand factor is modifiedby ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels”. 《Arterioscler Thromb Vasc Biol》 22 (2): 335–41. doi:10.1161/hq0202.103997. PMID 11834538. S2CID 325644.
Gill, JC; Endres-Brooks J; Bauer PJ; Marks WJ; Montgomery RR (June 1987). “The effect of ABO blood group on the diagnosis of von Willebrand disease”. 《Blood》 69 (6): 1691–5. doi:10.1182/blood.V69.6.1691.1691. PMID 3495304.
Shima, M; Fujimura Y; 외. (1995). “ABO blood group genotype and plasma von Willebrand factor in normal individuals”. 《Vox Sang》 68 (4): 236–40. doi:10.1111/j.1423-0410.1995.tb02579.x. PMID 7660643. S2CID 11582510.
Bowen, DJ; Collins PW; 외. (March 2005). “The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype”. 《Br J Haematol》 128 (6): 830–6. doi:10.1111/j.1365-2141.2005.05375.x. PMID 15755288. S2CID 45434815.
Bongers T; de Maat M; van Goor M; 외. (2006). “High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability”. 《Stroke》 37 (11): 2672–7. doi:10.1161/01.STR.0000244767.39962.f7. PMID 16990571.
Landsteiner, Karl (1961) [1901]. “On Agglutination of Normal Human Blood”. 《Transfusion》 1 (1): 5–8. doi:10.1111/j.1537-2995.1961.tb00005.x. ISSN 0041-1132. PMID 13758692. S2CID 40158397Originally published in German in Wiener Klinische Wochenschrift, 46, 1132–1134
Durand, J.K.; Willis, M.S. (2010). “Karl Landsteiner, MD: Transfusion Medicine”. 《Laboratory Medicine》 41 (1): 53–55. doi:10.1309/LM0MICLH4GG3QNDC. ISSN 0007-5027.
Farr AD (April 1979). “Blood group serology—the first four decades (1900–1939)”. 《Medical History》 23 (2): 215–26. doi:10.1017/S0025727300051383. ISSN 0025-7273. PMC 1082436. PMID 381816.
Doan, C.A. (1927). “The Transfusion problem”. 《Physiological Reviews》 7 (1): 1–84. doi:10.1152/physrev.1927.7.1.1. ISSN 0031-9333.
Schmidt, P.; Okroi, M. (2001). “Also sprach Landsteiner – Blood Group 'O' or Blood Group 'NULL'”. 《Transfusion Medicine and Hemotherapy》 28 (4): 206–208. doi:10.1159/000050239. ISSN 1660-3796. S2CID 57677644.
Garratty, G.; Dzik, W.; Issitt, P.D.; Lublin, D.M.; Reid, M.E.; Zelinski, T. (2000). “Terminology for blood group antigens and genes-historical origins and guidelines in the new millennium”. 《Transfusion》 40 (4): 477–489. doi:10.1046/j.1537-2995.2000.40040477.x. ISSN 0041-1132. PMID 10773062. S2CID 23291031.

dongascience.com

m.dongascience.com

gifu-u.ac.jp

www1.gifu-u.ac.jp

Kantha, S.S. (1995). “The blood revolution initiated by the famous footnote of Karl Landsteiner's 1900 paper” (PDF). 《The Ceylon Medical Journal》 40 (3): 123–125. PMID 8536328. 2018년 8월 30일에 원본 문서 (PDF)에서 보존된 문서. 2022년 12월 31일에 확인함.

harvard.edu

adsabs.harvard.edu

Segurel, L.; Thompson, E. E.; Flutre, T.; Lovstad, J.; Venkat, A.; Margulis, S. W.; Moyse, J.; Ross, S.; Gamble, K.; Sella, G.; Ober, C. (2012). “The ABO blood group is a trans-species polymorphism in primates”. 《Proceedings of the National Academy of Sciences》 (영어) 109 (45): 18493–18498. arXiv:1208.4613. Bibcode:2012PNAS..10918493S. doi:10.1073/pnas.1210603109. PMC 3494955. PMID 23091028.

isbtweb.org

“ISBT: Red Cell Immunogenetics and Blood Group Terminology”. 《www.isbtweb.org》 (영어). 2022년 2월 2일에 원본 문서에서 보존된 문서. 2022년 2월 12일에 확인함.

kosis.kr

“병역판정검사 현황”. 《KOSIS》. 2022년 12월 31일에 확인함.

metapress.com

resources.metapress.com

Jan Van Oss, Carel (2004). “Letter to the Editor: "Natural" Versus Regular Antibodies”. 《The Protein Journal》 23 (6): 357; author reply 359–60. doi:10.1023/B:JOPC.0000039625.56296.6e. PMID 15517982. S2CID 189929325. 2011년 7월 14일에 원본 문서에서 보존된 문서. 2009년 11월 28일에 확인함.

nih.gov

ncbi.nlm.nih.gov

Storry, J. R.; Castilho, L.; Chen, Q.; Daniels, G.; Denomme, G.; Flegel, W. A.; Gassner, C.; de Haas, M.; 외. (2016). “International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings”. 《ISBT Science Series》 11 (2): 118–122. doi:10.1111/voxs.12280. ISSN 1751-2816. PMC 5662010. PMID 29093749.
Muramatsu M, Gonzalez HD, Cacciola R, Aikawa A, Yaqoob MM, Puliatti C (2014). “ABO incompatible renal transplants: Good or bad?”. 《World Journal of Transplantation》 4 (1): 18–29. doi:10.5500/wjt.v4.i1.18. ISSN 2220-3230. PMC 3964193. PMID 24669364.
Segurel, L.; Thompson, E. E.; Flutre, T.; Lovstad, J.; Venkat, A.; Margulis, S. W.; Moyse, J.; Ross, S.; Gamble, K.; Sella, G.; Ober, C. (2012). “The ABO blood group is a trans-species polymorphism in primates”. 《Proceedings of the National Academy of Sciences》 (영어) 109 (45): 18493–18498. arXiv:1208.4613. Bibcode:2012PNAS..10918493S. doi:10.1073/pnas.1210603109. PMC 3494955. PMID 23091028.
Seltsam A, Hallensleben M, Kollmann A, Blasczyk R (2003). “The nature of diversity and diversification at the ABO locus”. 《Blood》 102 (8): 3035–42. doi:10.1182/blood-2003-03-0955. PMID 12829588.
Ogasawara K; Bannai M; Saitou N; 외. (1996). “Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes”. 《Human Genetics》 97 (6): 777–83. doi:10.1007/BF02346189. PMID 8641696. S2CID 12076999.
Shastry, S; Bhat, S (October 2010). “Imbalance in A2 and A2B phenotype frequency of ABO group in South India”. 《Blood Transfusion》 8 (4): 267–270. doi:10.2450/2010.0147-09. PMC 2957492. PMID 20967168.
Cserti, CM; Dzik, WH (2007). “The ABO blood group system and Plasmodium falciparum malaria”. 《Blood》 110 (7): 2250–2258. doi:10.1182/blood-2007-03-077602. PMID 17502454.
Calafell, Francesc; 외. (September 2008). “Evolutionary dynamics of the human ABO gene”. 《Human Genetics》 124 (2): 123–135. doi:10.1007/s00439-008-0530-8. PMID 18629539. S2CID 12450238.
Jan Van Oss, Carel (2004). “Letter to the Editor: "Natural" Versus Regular Antibodies”. 《The Protein Journal》 23 (6): 357; author reply 359–60. doi:10.1023/B:JOPC.0000039625.56296.6e. PMID 15517982. S2CID 189929325. 2011년 7월 14일에 원본 문서에서 보존된 문서. 2009년 11월 28일에 확인함.
Seymour, R. M.; Allan, M. J.; Pomiankowski, A; Gustafsson, K (2004). “Evolution of the human ABO polymorphism by two complementary selective pressures”. 《Proceedings of the Royal Society B: Biological Sciences》 271 (1543): 1065–1072. doi:10.1098/rspb.2004.2674. PMC 1691687. PMID 15293861.
Reid, ME; Mohandas, N (2004). “Red blood cell blood group antigens: structure and function.”. 《Seminars in Hematology》 41 (2): 93–117. doi:10.1053/j.seminhematol.2004.01.001. PMID 15071789.
Mohandas, N; Narla, A (2005). “Blood group antigens in health and disease.”. 《Current Opinion in Hematology》 12 (2): 135–40. doi:10.1097/01.moh.0000153000.09585.79. PMID 15725904. S2CID 19866834.
Sarode, R; Goldstein J; Sussman II; Nagel RL; Tsai HM (June 2000). “Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor”. 《Br J Haematol》 109 (4): 857–64. doi:10.1046/j.1365-2141.2000.02113.x. PMID 10929042. S2CID 25343413.
O'Donnell, J; Laffan MA (August 2001). “The relationship between ABO histo-blood group, factor VIII and von Willebrand factor”. 《Transfus Med.》 11 (4): 343–51. doi:10.1046/j.1365-3148.2001.00315.x. PMID 11532189. S2CID 23603864.
O'Donnell, J; Boulton FE; Manning RA; Laffan MA (2002년 2월 1일). “Amount of H antigen expressed on circulating von Willebrand factor is modifiedby ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels”. 《Arterioscler Thromb Vasc Biol》 22 (2): 335–41. doi:10.1161/hq0202.103997. PMID 11834538. S2CID 325644.
Gill, JC; Endres-Brooks J; Bauer PJ; Marks WJ; Montgomery RR (June 1987). “The effect of ABO blood group on the diagnosis of von Willebrand disease”. 《Blood》 69 (6): 1691–5. doi:10.1182/blood.V69.6.1691.1691. PMID 3495304.
Shima, M; Fujimura Y; 외. (1995). “ABO blood group genotype and plasma von Willebrand factor in normal individuals”. 《Vox Sang》 68 (4): 236–40. doi:10.1111/j.1423-0410.1995.tb02579.x. PMID 7660643. S2CID 11582510.
Bowen, DJ; Collins PW; 외. (March 2005). “The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype”. 《Br J Haematol》 128 (6): 830–6. doi:10.1111/j.1365-2141.2005.05375.x. PMID 15755288. S2CID 45434815.
Bongers T; de Maat M; van Goor M; 외. (2006). “High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability”. 《Stroke》 37 (11): 2672–7. doi:10.1161/01.STR.0000244767.39962.f7. PMID 16990571.
Kantha, S.S. (1995). “The blood revolution initiated by the famous footnote of Karl Landsteiner's 1900 paper” (PDF). 《The Ceylon Medical Journal》 40 (3): 123–125. PMID 8536328. 2018년 8월 30일에 원본 문서 (PDF)에서 보존된 문서. 2022년 12월 31일에 확인함.
Landsteiner, Karl (1961) [1901]. “On Agglutination of Normal Human Blood”. 《Transfusion》 1 (1): 5–8. doi:10.1111/j.1537-2995.1961.tb00005.x. ISSN 0041-1132. PMID 13758692. S2CID 40158397Originally published in German in Wiener Klinische Wochenschrift, 46, 1132–1134
Farr AD (April 1979). “Blood group serology—the first four decades (1900–1939)”. 《Medical History》 23 (2): 215–26. doi:10.1017/S0025727300051383. ISSN 0025-7273. PMC 1082436. PMID 381816.
Farhud, D.D.; Zarif Yeganeh, M. (2013). “A brief history of human blood groups”. 《Iranian Journal of Public Health》 42 (1): 1–6. PMC 3595629. PMID 23514954. )
Garratty, G.; Dzik, W.; Issitt, P.D.; Lublin, D.M.; Reid, M.E.; Zelinski, T. (2000). “Terminology for blood group antigens and genes-historical origins and guidelines in the new millennium”. 《Transfusion》 40 (4): 477–489. doi:10.1046/j.1537-2995.2000.40040477.x. ISSN 0041-1132. PMID 10773062. S2CID 23291031.

sciam.com

Klein, Harvey G (2005년 3월 7일). “Why Do People Have Different Blood Types?”. 《Scientific American》. 2007년 11월 16일에 확인함.

semanticscholar.org

api.semanticscholar.org

Ogasawara K; Bannai M; Saitou N; 외. (1996). “Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes”. 《Human Genetics》 97 (6): 777–83. doi:10.1007/BF02346189. PMID 8641696. S2CID 12076999.
Calafell, Francesc; 외. (September 2008). “Evolutionary dynamics of the human ABO gene”. 《Human Genetics》 124 (2): 123–135. doi:10.1007/s00439-008-0530-8. PMID 18629539. S2CID 12450238.
Jan Van Oss, Carel (2004). “Letter to the Editor: "Natural" Versus Regular Antibodies”. 《The Protein Journal》 23 (6): 357; author reply 359–60. doi:10.1023/B:JOPC.0000039625.56296.6e. PMID 15517982. S2CID 189929325. 2011년 7월 14일에 원본 문서에서 보존된 문서. 2009년 11월 28일에 확인함.
Mohandas, N; Narla, A (2005). “Blood group antigens in health and disease.”. 《Current Opinion in Hematology》 12 (2): 135–40. doi:10.1097/01.moh.0000153000.09585.79. PMID 15725904. S2CID 19866834.
Sarode, R; Goldstein J; Sussman II; Nagel RL; Tsai HM (June 2000). “Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor”. 《Br J Haematol》 109 (4): 857–64. doi:10.1046/j.1365-2141.2000.02113.x. PMID 10929042. S2CID 25343413.
O'Donnell, J; Laffan MA (August 2001). “The relationship between ABO histo-blood group, factor VIII and von Willebrand factor”. 《Transfus Med.》 11 (4): 343–51. doi:10.1046/j.1365-3148.2001.00315.x. PMID 11532189. S2CID 23603864.
O'Donnell, J; Boulton FE; Manning RA; Laffan MA (2002년 2월 1일). “Amount of H antigen expressed on circulating von Willebrand factor is modifiedby ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels”. 《Arterioscler Thromb Vasc Biol》 22 (2): 335–41. doi:10.1161/hq0202.103997. PMID 11834538. S2CID 325644.
Shima, M; Fujimura Y; 외. (1995). “ABO blood group genotype and plasma von Willebrand factor in normal individuals”. 《Vox Sang》 68 (4): 236–40. doi:10.1111/j.1423-0410.1995.tb02579.x. PMID 7660643. S2CID 11582510.
Bowen, DJ; Collins PW; 외. (March 2005). “The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype”. 《Br J Haematol》 128 (6): 830–6. doi:10.1111/j.1365-2141.2005.05375.x. PMID 15755288. S2CID 45434815.
Landsteiner, Karl (1961) [1901]. “On Agglutination of Normal Human Blood”. 《Transfusion》 1 (1): 5–8. doi:10.1111/j.1537-2995.1961.tb00005.x. ISSN 0041-1132. PMID 13758692. S2CID 40158397Originally published in German in Wiener Klinische Wochenschrift, 46, 1132–1134
Schmidt, P.; Okroi, M. (2001). “Also sprach Landsteiner – Blood Group 'O' or Blood Group 'NULL'”. 《Transfusion Medicine and Hemotherapy》 28 (4): 206–208. doi:10.1159/000050239. ISSN 1660-3796. S2CID 57677644.
Garratty, G.; Dzik, W.; Issitt, P.D.; Lublin, D.M.; Reid, M.E.; Zelinski, T. (2000). “Terminology for blood group antigens and genes-historical origins and guidelines in the new millennium”. 《Transfusion》 40 (4): 477–489. doi:10.1046/j.1537-2995.2000.40040477.x. ISSN 0041-1132. PMID 10773062. S2CID 23291031.

socalredcross.org

American Red Cross, Southern California Blood Services Region (n.d.). “Answers to Commonly Asked Questions About Blood and Blood Banking” (PDF). 《Blood: The Basics》: 4. 2007년 11월 29일에 원본 문서 (PDF)에서 보존된 문서. 2007년 11월 16일에 확인함.

web.archive.org

“ISBT: Red Cell Immunogenetics and Blood Group Terminology”. 《www.isbtweb.org》 (영어). 2022년 2월 2일에 원본 문서에서 보존된 문서. 2022년 2월 12일에 확인함.
Blood Group A Suptypes, The Owen Foundation. Retrieved 1 July 2008.
Jan Van Oss, Carel (2004). “Letter to the Editor: "Natural" Versus Regular Antibodies”. 《The Protein Journal》 23 (6): 357; author reply 359–60. doi:10.1023/B:JOPC.0000039625.56296.6e. PMID 15517982. S2CID 189929325. 2011년 7월 14일에 원본 문서에서 보존된 문서. 2009년 11월 28일에 확인함.
Kantha, S.S. (1995). “The blood revolution initiated by the famous footnote of Karl Landsteiner's 1900 paper” (PDF). 《The Ceylon Medical Journal》 40 (3): 123–125. PMID 8536328. 2018년 8월 30일에 원본 문서 (PDF)에서 보존된 문서. 2022년 12월 31일에 확인함.
American Red Cross, Southern California Blood Services Region (n.d.). “Answers to Commonly Asked Questions About Blood and Blood Banking” (PDF). 《Blood: The Basics》: 4. 2007년 11월 29일에 원본 문서 (PDF)에서 보존된 문서. 2007년 11월 16일에 확인함.

worldcat.org

Storry, J. R.; Castilho, L.; Chen, Q.; Daniels, G.; Denomme, G.; Flegel, W. A.; Gassner, C.; de Haas, M.; 외. (2016). “International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings”. 《ISBT Science Series》 11 (2): 118–122. doi:10.1111/voxs.12280. ISSN 1751-2816. PMC 5662010. PMID 29093749.
Muramatsu M, Gonzalez HD, Cacciola R, Aikawa A, Yaqoob MM, Puliatti C (2014). “ABO incompatible renal transplants: Good or bad?”. 《World Journal of Transplantation》 4 (1): 18–29. doi:10.5500/wjt.v4.i1.18. ISSN 2220-3230. PMC 3964193. PMID 24669364.
Landsteiner, Karl (1961) [1901]. “On Agglutination of Normal Human Blood”. 《Transfusion》 1 (1): 5–8. doi:10.1111/j.1537-2995.1961.tb00005.x. ISSN 0041-1132. PMID 13758692. S2CID 40158397Originally published in German in Wiener Klinische Wochenschrift, 46, 1132–1134
Durand, J.K.; Willis, M.S. (2010). “Karl Landsteiner, MD: Transfusion Medicine”. 《Laboratory Medicine》 41 (1): 53–55. doi:10.1309/LM0MICLH4GG3QNDC. ISSN 0007-5027.
Farr AD (April 1979). “Blood group serology—the first four decades (1900–1939)”. 《Medical History》 23 (2): 215–26. doi:10.1017/S0025727300051383. ISSN 0025-7273. PMC 1082436. PMID 381816.
Doan, C.A. (1927). “The Transfusion problem”. 《Physiological Reviews》 7 (1): 1–84. doi:10.1152/physrev.1927.7.1.1. ISSN 0031-9333.
Schmidt, P.; Okroi, M. (2001). “Also sprach Landsteiner – Blood Group 'O' or Blood Group 'NULL'”. 《Transfusion Medicine and Hemotherapy》 28 (4): 206–208. doi:10.1159/000050239. ISSN 1660-3796. S2CID 57677644.
Garratty, G.; Dzik, W.; Issitt, P.D.; Lublin, D.M.; Reid, M.E.; Zelinski, T. (2000). “Terminology for blood group antigens and genes-historical origins and guidelines in the new millennium”. 《Transfusion》 40 (4): 477–489. doi:10.1046/j.1537-2995.2000.40040477.x. ISSN 0041-1132. PMID 10773062. S2CID 23291031.